Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 13, Number 1—January 2007

Research

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England

Cheryl Cohen*1Comments to Author , Joanne M. White†, Emma J. Savage†, Judith R. Glynn*, Yoon Choi†, Nick Andrews†, David Brown†, and Mary E. Ramsay†
Author affiliations: *London School of Hygiene and Tropical Medicine, London, United Kingdom; †Health Protection Agency Centre for Infections, London, United Kingdom; 1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Main Article

Table 2

Estimated coverage of measles, mumps, rubella vaccine at 2 and 5 years of age by area and birth cohort

Birth cohort*% Coverage at 2 years of age
% Coverage at 5 years of age
Outside London
London
Outside London
London
1 dose1 dose>1 dose2 doses>1 dose2 doses
1993–199492.777.195.778.188.657.1
1994–199592.076.695.078.387.956.3
1995–199691.976.094.976.485.059.6
1996–199790.473.393.476.784.558.0
1997–199888.869.792.076.882.956.8
1998–199989.069.592.377.681.356.3
1999–200086.965.891.377.380.156.8
2000–200185.364.590.176.478.955.8
2001–200280.659.4
2002–200382.760.3

*Birth cohorts for school year (i.e., children born October 1–September 30 of the following year).

Main Article

1Current affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa, and University of the Witwatersrand School of Public Health, Parktown, South Africa

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO